Literature DB >> 4086474

The specific glycosphingolipid composition of human ureteral epithelial cells.

M E Breimer, G C Hansson, H Leffler.   

Abstract

Total non-acid and acid glycolipid fractions were isolated from epithelial cell scrapings and the non-epithelial residue of a human upper ureter. The glycolipid fractions were structurally characterized as total mixtures by thin-layer chromatography, mass spectrometry, and proton NMR spectroscopy. Selected structural information was also obtained on binding of monoclonal antibodies and bacteria to the thin-layer chromatograms. The major epithelial cell glycolipids were Glc beta 1-1ceramide (75%), dihexosylceramide (10%) and NeuAcLacceramide (10%). In addition, 8 minor glycolipids belonging to the blood group P, Lewis and ABO systems were identified. The major glycolipids of the non-epithelial residues were mono- and dihexosylceramides together with globotriaosyl- and globotetraosylceramides. The epithelial mono- and diglycosylceramide compounds had an unusual ceramide composition with mainly C18 and C20 trihydroxy long chain bases in combination with C22-C24 hydroxy fatty acids in contrast to the non-epithelial glycolipids which contained mainly C18 dihydroxy long chain bases in combination with C16-C24 non-hydroxy fatty acids.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4086474     DOI: 10.1093/oxfordjournals.jbchem.a135383

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney.

Authors:  J F Karr; B J Nowicki; L D Truong; R A Hull; J J Moulds; S I Hull
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Binding characteristics of Escherichia coli adhesins in human urinary bladder.

Authors:  R Virkola; B Westerlund; H Holthöfer; J Parkkinen; M Kekomäki; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

3.  Adherence of oral streptococci to salivary glycoproteins.

Authors:  P A Murray; A Prakobphol; T Lee; C I Hoover; S J Fisher
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 4.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Authors:  Hiroko Hama
Journal:  Biochim Biophys Acta       Date:  2009-12-21

5.  Binding of N-trifluoroacetyl-derivatized natural glycosphingolipids by uropathogenic Escherichia coli and Neisseria subflava.

Authors:  B Lanne; J Angström; M Olwegård; S Teneberg; G Stenhagen; K A Karlsson; E Nilsson
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

6.  Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection.

Authors:  T Sandberg; B Kaijser; G Lidin-Janson; K Lincoln; F Orskov; I Orskov; E Stokland; C Svanborg-Edén
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

7.  Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds.

Authors:  J Holgersson; P A Jovall; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

8.  Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.

Authors:  A Stapleton; E Nudelman; H Clausen; S Hakomori; W E Stamm
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Receptor-specific agglutination tests for detection of bacteria that bind globoseries glycolipids.

Authors:  P de Man; B Cedergren; S Enerbäck; A C Larsson; H Leffler; A L Lundell; B Nilsson; C Svanborg-Edén
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

10.  Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors.

Authors:  N Strömberg; B I Marklund; B Lund; D Ilver; A Hamers; W Gaastra; K A Karlsson; S Normark
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.